Metabolomics Identifies Biomarker Pattern for Early Diagnosis of Hepatocellular Carcinoma: From Diethylnitrosamine Treated Rats to Patients

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zeng, Jun ^a   Huang, Xin ^b   Zhou, Lina ^a   Tan, Yexiong ^c   Hu, Chunxiu ^a   Wang, Xiaomei ^d   Niu, Junqi ^d   Wang, Hongyang ^c   Lin, Xiaohui ^b   Yin, Peiyuan ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BETAINE; CREATINE; DIETHYLNITROSAMINE; TUMOR MARKER;

ANIMAL; BLOOD; CARCINOMA, HEPATOCELLULAR; CHEMICALLY INDUCED; COHORT ANALYSIS; DISEASE MODEL; EARLY DIAGNOSIS; FEMALE; HUMAN; LIVER NEOPLASMS; MALE; METABOLOMICS; MULTIVARIATE ANALYSIS; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ALPHA-FETOPROTEINS; ANIMALS; BETAINE; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; CREATINE; DIETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; EARLY DIAGNOSIS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; METABOLOMICS; MULTIVARIATE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84946574328     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16101     Document Type: Article

References (29)

1. Kassahun, W. T., Fangmann, J., Harms, J., Hauss, J. and Bartels, M. Liver resection and transplantation in the management of hepatocellular carcinoma: a review. Exp Clin Transplant 4, 549-558 (2006).
2. Chen, T. L. et al. Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma. Mol. Cell. Proteomics 10, doi: 10.1074/mcp.M110.004945 (2011).
3. El-Serag, H. B. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma. Gastroenterology 142, 1264-+ , doi: 10.1053/j. gastro.2011.12.061 (2012).
4. Chen, J. G. and Zhang, S. W. Liver cancer epidemic in China: Past, present and future. Semin. Cancer Biol. 21, 59-69, doi: 10.1016/j. semcancer.2010.11.002 (2011).
5. Schiffer, E. et al. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology 41, 307-314, doi: 10.1002/hep.20538 (2005).
6. Ryder, S. D. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 52, III1-III8, doi: 10.1136/gut.52.suppl-3.iii1 (2003).
7. Parikh, S. and Hyman, D. Hepatocellular cancer: A guide for the internist. Am. J. Med. 120, 194-202, doi: 10.1016/j. amjmed.2006.11.020 (2007).
8. Colli, A. et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: A systematic review. Am. J. Gastroenterol. 101, 513-523, doi: 10.1111/j.1572-0241.2006.00467.x (2006).
9. Cantor, J. R. and Sabatini, D. M. Cancer Cell Metabolism: One Hallmark, Many Faces. Cancer Discovery 2, 881-898, doi: 10.1158/2159-8290.cd-12-0345 (2012).
10. Sreekumar, A. et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914, doi: 10.1038/nature07762 (2009).
11. Jain, M. et al. Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation. Science 336, 1040-1044, doi: 10.1126/science.1218595 (2012).
12. Hirayama, A. et al. Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass Spectrometry. Cancer Res. 69, 4918-4925, doi: 10.1158/0008-5472.can-08-4806 (2009).
13. Soga, T. et al. Serum metabolomics reveals gamma-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease. J. Hepatol. 55, 896-905 (2011).
14. Wang, B. H. et al. Metabonomic Profiles Discriminate Hepatocellular Carcinoma from Liver Cirrhosis by Ultraperformance Liquid Chromatography-Mass Spectrometry. J. Proteome Res. 11, 1217-1227, doi: 10.1021/pr2009252 (2012).
15. Yin, P. Y. et al. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry. Mol. BioSyst. 5, 868-876, doi: 10.1039/b820224a (2009).
16. Chen, J. et al. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Anal. Chim. Acta 650, 3-9, doi: 10.1016/j.aca.2009.03.039 (2009).
17. Lee, J. S. et al. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat. Genet. 36, 1306-1311, doi: 10.1038/ng1481 (2004).
18. Pitot, H. C., Dragan, Y. P., Teeguarden, J., Hsia, S. and Campbell, H. Quantitation of multistage carcinogenesis in rat liver. Toxicol. Pathol. 24, 119-128 (1996).
19. Aleksic, K. et al. Evolution of Genomic Instability in Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice. Hepatology 53, 895-904, doi: 10.1002/hep.24133 (2011).
20. Tan, Y. X. et al. Metabolomics Study of Stepwise Hepatocarcinogenesis From the Model Rats to Patients: Potential Biomarkers Effective for Small Hepatocellular Carcinoma Diagnosis. Mol. Cell. Proteomics 11, doi: 10.1074/mcp.M111.010694 (2012).
21. Zeng, J. et al. Metabolomics Study of Hepatocellular Carcinoma: Discovery and Validation of Serum Potential Biomarkers by Using Capillary Electrophoresis-Mass Spectrometry. J. Proteome Res., doi: 10.1021/pr500390y (2014).
22. Gao, P. et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458, 762-U100, doi: 10.1038/nature07823 (2009).
23. Stead, L. M., Brosnan, J. T., Brosnan, M. E., Vance, D. E. and Jacobs, R. L. Is it time to reevaluate methyl balance in humans? Am. J. Clin. Nutr. 83, 5-10 (2006).
24. Pradeep, K., Mohan, C. V. R., Gobianand, K. and Karthikeyan, S. Silymarin modulates the oxidant-antioxidant imbalance during diethylnitrosamine induced oxidative stress in rats. Eur. J. Pharmacol. 560, 110-116, doi: 10.1016/j.ejphar.2006.12.023 (2007).
25. Paula Santos, N. et al. N-diethylnitrosamine mouse hepatotoxicity: time-related effects on histology and oxidative stress. Exp. Toxicol. Pathol. 66, 429-436, doi: 10.1016/j.etp.2014.07.002 (2014).
26. Ziech, D. et al. The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. Chem.-Biol. Interact. 188, 334-339, doi: 10.1016/j.cbi.2010.07.010 (2010).
27. Mato, J. M., Martinez-Chantar, M. L. and Lu, S. C. In Annu. Rev. Nutr. Vol. 28 Annual Review of Nutrition 273-293 (Annual Reviews, 2008).
28. Cholewa, J. M., Guimaraes-Ferreira, L. and Zanchi, N. E. Effects of betaine on performance and body composition: a review of recent findings and potential mechanisms. Amino Acids 46, 1785-1793, doi: 10.1007/s00726-014-1748-5 (2014).
29. Yin, P. et al. Preanalytical Aspects and Sample Quality Assessment in Metabolomics Studies of Human Blood. Clin. Chem., doi: 10.1373/clinchem.2012.199257 (2013).